I navigated each of those disruptions inside HBO, one of the most beloved and high-profile cultural brands in the world. Bold ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In the AI value chain, application-layer leaders like Palantir and ServiceNow may win long term as chip/cloud margins ...

Buffer overflow vulnerabilities have driven remote code execution for decades and keep appearing in critical network ...

Building a model capable of RSI would require automating a range of specialist tasks currently carried out by humans. At present data scientists work on the theory of AI and coders put it into ...

Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and ...

The AWS SDK for JavaScript v3 is a rewrite of v2 with some great new features. As with version 2, it enables you to easily work with Amazon Web Services, but has a modular architecture with a separate ...

Abstract: Return-oriented programming (ROP) attacks pose a significant threat to the control-flow integrity (CFI) of Internet of Things (IoT) devices, which operate in resource-constrained ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Even as leading AI providers like OpenAI and Anthropic battle over the compute to train and release ever larger, more powerful models, other labs are going in a different direction — pursuing the ...